PRESS RELEASE published on 05/18/2026 at 17:19, 4 months ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (ISIN: FR0004056851) research, maintains Buy recommendation with lowered price target. Q1/26 sales declined by 37.2% to €30.9m. Market awaiting Pfizer's BLA submission for Lyme disease vaccine candidate LB6V Buy Recommendation Research Update Valneva SE Q1/26 Sales Pfizer BLA Submission
BRIEF published on 05/06/2026 at 11:41, 4 months 12 days ago Valneva announces the publication of its financial results for the first quarter of 2026 Financial Results Web Conference Clinical Development Valneva Vaccines
PRESS RELEASE published on 05/06/2026 at 11:36, 4 months 12 days ago Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Valneva SE to report First Quarter 2026 Consolidated Financial Results on May 13, 2026. Live webcast available for discussion and business update Financial Results Business Update Valneva SE Live Webcast Vaccine Company
BRIEF published on 03/31/2026 at 14:30, 5 months 18 days ago Valneva's Lyme Disease Vaccine Shows Promise Despite Missed Trial Endpoint FDA Approval Price Target Phase 3 Trial Valneva SE Lyme Disease Vaccine
PRESS RELEASE published on 03/31/2026 at 14:25, 5 months 18 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (FR0004056851) analysis post Lyme phase 3 trial topline results with Pfizer. Despite missing primary endpoint, optimism remains for FDA approval FDA Approval First Berlin Equity Research Valneva SE Pfizer Lyme Vaccine
BRIEF published on 03/26/2026 at 17:50, 5 months 23 days ago Valneva at the 25th World Vaccine Congress in Washington Valneva World Vaccine Congress Clinical Studies Vaccination Chikungunya
BRIEF published on 03/23/2026 at 12:22, 5 months 26 days ago Pfizer and Valneva unveil promising results for their Lyme disease vaccine Valneva Vaccine Phase 3 Pfizer Lyme
BRIEF published on 02/20/2026 at 12:01, 6 months 26 days ago Valneva SE: Research Update and Financial Projections Valneva SE Financial Update Lyme Vaccine Third-Party Sales Target Price Adjustments
PRESS RELEASE published on 02/20/2026 at 11:56, 6 months 26 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH updated Valneva SE's classification to Buy with a target price of €6.60. Details on 2025 revenues, cash figures, and 2026 guidance included Buy Recommendation Valneva SE First Berlin Equity Research GmbH 2025 Revenues 2026 Guidance
BRIEF published on 01/09/2026 at 07:05, 8 months 9 days ago Valneva Engages Investors at J.P. Morgan Healthcare Conference Valneva Investor Meetings Lyme Disease Vaccine J.P. Morgan Conference Vaccine Portfolio
Published on 09/18/2026 at 22:00, 22 minutes ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 hour 47 minutes ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 7 hours 52 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 8 hours 52 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 15 hours 52 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 18:44, 3 hours 38 minutes ago EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:13, 4 hours 9 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:09, 4 hours 12 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:07, 4 hours 15 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:34, 3 hours 48 minutes ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 1 day 4 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
